Podcast: How Genentech is Innovating to Improve Diversity and Inclusion in Clinical Trials

The race to develop a COVID-19 vaccine shined a light on an issue that has challenged the pharmaceutical industry for years. Underrepresented minority communities are often disproportionately impacted by diseases, yet those groups are usually underrepresented in the clinical trials that are designed to assess the effectiveness of drugs that they need. As one of the world’s largest biotechnology companies, Genentech is tapping advanced mobile technology to help increase the diversity of trial participants and improve the experience.

Read the Full Article

Listen to this podcast where Genentech discusses their deployment of Lifelink’s conversational AI to increase clinical trial participation in diverse and under-served communities